{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T01:31:25Z","timestamp":1775611885399,"version":"3.50.1"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Lay Summary<\/jats:title>\n               <jats:p>Oral vancomycin shows promise in treating pouchitis in patients with primary sclerosing cholangitis and ulcerative colitis. In this study, vancomycin helped reduce stool frequency, urgency, and incontinence. More research is needed to confirm its long-term benefits and best treatment practices.<\/jats:p>","DOI":"10.1093\/ibd\/izaf117","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T12:48:21Z","timestamp":1751287701000},"page":"2597-2601","source":"Crossref","is-referenced-by-count":1,"title":["Oral Vancomycin as an Emerging Therapy for Inflammatory Pouch Conditions Associated With Primary Sclerosing Cholangitis"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9415-4577","authenticated-orcid":false,"given":"Katie","family":"Dunleavy","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic , Rochester, MN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail","family":"Meyers","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Medical College of Wisconsin , Milwaukee ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Violante","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic , Rochester, MN ,","place":["USA"]},{"name":"Orsi Academy , Gent ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blake","family":"Kassmeyer","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Mayo Clinic , Rochester, MN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siri A","family":"Urquhart","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic , Rochester, MN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0775-4385","authenticated-orcid":false,"given":"Nayantara","family":"Coelho-Prabhu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic , Rochester, MN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5267-2592","authenticated-orcid":false,"given":"Laura","family":"Raffals","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic , Rochester, MN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9177-4586","authenticated-orcid":false,"given":"David","family":"Larson","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic , Rochester, MN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"issue":"6","key":"2025092307422416500_CIT0001","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1053\/j.gastro.2021.08.032","article-title":"Prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"161","author":"Barberio","year":"2021","journal-title":"Gastroenterology."},{"issue":"1","key":"2025092307422416500_CIT0002","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1053\/j.gastro.2023.10.015","article-title":"AGA Clinical Practice Guideline on the management of pouchitis and inflammatory pouch disorders","volume":"166","author":"Barnes","year":"2024","journal-title":"Gastroenterology."},{"issue":"1","key":"2025092307422416500_CIT0003","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus J","year":"2005","journal-title":"Gut."},{"issue":"5","key":"2025092307422416500_CIT0004","doi-asserted-by":"publisher","first-page":"e964","DOI":"10.1016\/j.cgh.2021.02.006","article-title":"Primary sclerosing cholangitis-associated pouchitis: a distinct clinical phenotype","volume":"20","author":"Quinn","year":"2022","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"9","key":"2025092307422416500_CIT0005","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1002\/ibd.21594","article-title":"Primary sclerosing cholangitis is associated with endoscopic and histologic inflammation of the distal afferent limb in patients with ileal pouch-anal anastomosis","volume":"17","author":"Shen","year":"2011","journal-title":"Inflamm Bowel Dis."},{"key":"2025092307422416500_CIT0006","doi-asserted-by":"publisher","first-page":"izae257","DOI":"10.1093\/ibd\/izae257","article-title":"The effectiveness of oral vancomycin on inflammatory bowel disease in patients with primary sclerosing cholangitis: a systematic review","author":"Arbabzada","year":"2024","journal-title":"Inflamm Bowel Dis."},{"issue":"2","key":"2025092307422416500_CIT0007","doi-asserted-by":"publisher","first-page":"jjae189","DOI":"10.1093\/ecco-jcc\/jjae189","article-title":"Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel disease: improved colonic disease activity and associations with changes in host-microbiome-metabolomic signatures","volume":"19","author":"Quraishi","year":"2024","journal-title":"J Crohns Colitis."},{"issue":"10","key":"2025092307422416500_CIT0008","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/apt.17936","article-title":"Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): a matched analysis from the Paediatric PSC Consortium","volume":"59","author":"Ricciuto","year":"2024","journal-title":"Aliment Pharmacol Ther."},{"issue":"10","key":"2025092307422416500_CIT0009","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1093\/ibd\/izac043","article-title":"Vancomycin is effective in the treatment of chronic inflammatory conditions of the pouch","volume":"28","author":"Lupu","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"6","key":"2025092307422416500_CIT0010","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s10350-004-6652-8","article-title":"Modified pouchitis disease activity index: a simplified approach to the diagnosis of pouchitis","volume":"46","author":"Shen","year":"2003","journal-title":"Dis Colon Rectum."},{"issue":"2","key":"2025092307422416500_CIT0011","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cgh.2024.06.037","article-title":"Mucosal healing with vedolizumab in patients with chronic pouchitis: EARNEST, a randomized, double-blind, placebo-controlled trial","volume":"23","author":"Jairath","year":"2025","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"3","key":"2025092307422416500_CIT0012","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/gastro\/goab004","article-title":"Oral vancomycin in the treatment of primary sclerosing cholangitis-associated pouchitis","volume":"9","author":"Shen","year":"2021","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"7","key":"2025092307422416500_CIT0013","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1093\/ibd\/izad288","article-title":"Altered bile acid and pouch microbiota composition in patients with chronic pouchitis","volume":"30","author":"Santiago","year":"2023","journal-title":"Inflamm Bowel Dis."},{"issue":"12","key":"2025092307422416500_CIT0014","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1093\/cid\/ciab898","article-title":"Medicare prescription plans limit access to recommended drugs for Clostridioides difficile infection","volume":"74","author":"Buehrle","year":"2021","journal-title":"Clin Infect Dis."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izaf117\/63629065\/izaf117.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/9\/2597\/63629065\/izaf117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/9\/2597\/63629065\/izaf117.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T11:45:21Z","timestamp":1758627921000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/31\/9\/2597\/8178732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":14,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,6,30]]},"published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaf117","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,6,30]]}}}